Expanding Allogeneic Stem Cell Transplantation for Relapsed and Refractory Acute Myeloid LeukemiaByMoneeza Walji, MD, MPH,Boglarka Gyurkocza, MDSeptember 9th 2023Allogeneic HCT has shown promise as definitive treatment for patients with relapsed or refractory AML.